Cargando…

An omics-based strategy using coenzyme Q10 in patients with Parkinson’s disease: concept evaluation in a double-blind randomized placebo-controlled parallel group trial

BACKGROUND: This study focuses on genetically stratified subgroups of Parkinson’s disease patients (PD) with an enrichment of risk variants in mitochondrial genes,who might benefit from treatment with the “mitochondrial enhancer” coenzyme Q10 (156 mg coenzyme Q10/d [QuinoMit Q10® Fluid] over six mon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prasuhn, Jannik, Brüggemann, Norbert, Hessler, Nicole, Berg, Daniela, Gasser, Thomas, Brockmann, Kathrin, Olbrich, Denise, Ziegler, Andreas, König, Inke R., Klein, Christine, Kasten, Meike
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Clinical Trial Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650116/ https://www.ncbi.nlm.nih.gov/pubmed/33324897 http://dx.doi.org/10.1186/s42466-019-0033-1

Ejemplares similares

The Use of Vitamin K2 in Patients With Parkinson's Disease and Mitochondrial Dysfunction (PD-K2): A Theranostic Pilot Study in a Placebo-Controlled Parallel Group Design
por: Prasuhn, Jannik, et al.
Publicado: (2021)

Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson’s disease
por: Prasuhn, Jannik, et al.
Publicado: (2022)

Genotype-driven therapeutic developments in Parkinson’s disease
por: Prasuhn, Jannik, et al.
Publicado: (2021)

Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson’s Disease
por: Prasuhn, Jannik, et al.
Publicado: (2021)

Applicability of optical coherence tomography angiography (OCTA) imaging in Parkinson’s disease
por: Lauermann, Jost L., et al.
Publicado: (2021)

Neuroimaging Methods to Map In Vivo Changes of OXPHOS and Oxidative Stress in Neurodegenerative Disorders
por: Prasuhn, Jannik, et al.
Publicado: (2022)

A machine learning-based classification approach on Parkinson’s disease diffusion tensor imaging datasets
por: Prasuhn, Jannik, et al.
Publicado: (2020)

Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson’s Disease
por: Pizarro-Galleguillos, Benjamin Matis, et al.
Publicado: (2022)

Neuroinflammation and Mitochondrial Dysfunction in Parkinson’s Disease: Connecting Neuroimaging with Pathophysiology
por: Pizarro-Galleguillos, Benjamin Matís, et al.
Publicado: (2023)

Radiosurgery for ventricular tachycardia: preclinical and clinical evidence and study design for a German multi-center multi-platform feasibility trial (RAVENTA)
por: Blanck, Oliver, et al.
Publicado: (2020)

Depressive symptoms in Parkinson’s disease are insufficiently but more often treated than in other chronic conditions
por: Usnich, Tatiana, et al.
Publicado: (2023)

Cardiac effects of amiselimod compared with fingolimod and placebo: results of a randomised, parallel‐group, phase I study in healthy subjects
por: Harada, Tomohiko, et al.
Publicado: (2017)

Neuroimaging in Primary Coenzyme-Q(10)-Deficiency Disorders
por: Münch, Juliane, et al.
Publicado: (2023)

Protocol of a randomized, double-blind, placebo-controlled, parallel-group, multicentre study of the efficacy and safety of nicotinamide in patients with Friedreich ataxia (NICOFA)
por: Reetz, Kathrin, et al.
Publicado: (2019)

Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism
por: Borsche, Max, et al.
Publicado: (2020)

Pregabalin to improve postoperative recovery in bariatric surgery: a parallel, randomized, double-blinded, placebo-controlled study
por: Martins, Marcelo J, et al.
Publicado: (2018)

Transient Generalized Chorea in Influenza A Encephalopathy
por: Prasuhn, Jannik, et al.
Publicado: (2018)

Effect of n-3 PUFA on extracellular matrix protein turnover in patients with psoriatic arthritis: a randomized, double-blind, placebo-controlled trial
por: Holm Nielsen, Signe, et al.
Publicado: (2021)

Metastases-directed Radiotherapy in Addition to Standard Systemic Therapy in Patients with Oligometastatic Breast Cancer: Study protocol for a randomized controlled multi-national and multi-center clinical trial (OLIGOMA)
por: Krug, David, et al.
Publicado: (2021)

Lifestyle factors and clinical severity of Parkinson’s disease
por: Gabbert, Carolin, et al.
Publicado: (2023)

Clinical MR imaging in Parkinson’s disease: How useful is the swallow tail sign?
por: Prasuhn, Jannik, et al.
Publicado: (2021)

Risky behaviors and Parkinson disease: A mendelian randomization study
por: Grover, Sandeep, et al.
Publicado: (2019)

Increased Subcortical Sodium Levels in Patients with Progressive Supranuclear Palsy
por: Prasuhn, Jannik, et al.
Publicado: (2022)

Discordance in monozygotic Parkinson's disease twins – continuum or dichotomy?
por: Balck, Alexander, et al.
Publicado: (2019)

Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
por: Goadsby, Peter J, et al.
Publicado: (2019)

How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory‐HTA parallel scientific advice
por: Tafuri, Giovanni, et al.
Publicado: (2016)

Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study
por: Tolaney, Sara M., et al.
Publicado: (2016)

Adjuvant use of melatonin for pain management in dysmenorrhea — a randomized double-blinded, placebo-controlled trial
por: Söderman, Lisa, et al.
Publicado: (2021)

Nasal administration of a probiotic assemblage in allergic rhinitis: A randomised placebo‐controlled crossover trial
por: Mårtensson, Anders, et al.
Publicado: (2022)

A Randomized, Double‐Blind, Placebo‐Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Study
por: Riedel, Richard F., et al.
Publicado: (2020)

Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized, Placebo‐Controlled Trial
por: Wong, Rachel HX, et al.
Publicado: (2020)

Bacterial lysate add‐on therapy to reduce exacerbations in severe asthma: A double‐blind placebo‐controlled trial
por: de Boer, Geertje M., et al.
Publicado: (2021)

Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial
por: Nomura, Takashi, et al.
Publicado: (2021)

The effect of BI 409306 on heart rate in healthy volunteers: a randomised, double-blind, placebo-controlled, crossover study
por: Müller, Fabian, et al.
Publicado: (2022)

Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo‐Controlled, Double‐Blind Phase 2 Trial
por: Pignolo, Robert J., et al.
Publicado: (2022)

Long‐Term Selenium‐Yeast Supplementation Does Not Affect Bone Turnover Markers: A Randomized Placebo‐Controlled Trial
por: Perri, Giorgia, et al.
Publicado: (2022)

Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study
por: Mendzelevski, Boaz, et al.
Publicado: (2012)

Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain
por: Konno, Shinichi, et al.
Publicado: (2016)

Adrenomedullin for biologic‐resistant Crohn's disease: A randomized, double‐blind, placebo‐controlled phase 2a clinical trial
por: Kita, Toshihiro, et al.
Publicado: (2022)

The MARVEL trial: a phase 2b randomised placebo-controlled trial of oral MitoQ in moderate ulcerative colitis
por: Gwyer Findlay, Emily, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kktfi9hfr6se33nqf3f8usli78